Paper32864635
Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.
Reighard SD and 11 others. Cell Rep Med, 2020. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. Papers, record 32864635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32864635
- Cell line
- HEK293T2,726 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| T-Lymphocytes | Major topic |
| Adult | |
| Animals | |
| Autoimmune Diseases | |
| Autoimmunity | |
| Cells, Cultured | |
| Child | |
| Child, Preschool | |
| Drosophila melanogaster | |
| Female | |
| Humans | |
| Immunotherapy, Adoptive | |
| Male | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| Mice, Transgenic |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DP1 DA038017 | NIDA NIH HHS | United States | DP1DA038017 | PubMed and NIH | NIH RePORTER |
| R01 AR073228 | NIAMS NIH HHS | United States | R01AR073228 | PubMed and NIH | NIH RePORTER |
| S10 OD023410 | NIH HHS | United States | S10OD023410 | PubMed and NIH | NIH RePORTER |
| R01 AI148080 | NIAID NIH HHS | United States | R01AI148080 | PubMed and NIH | NIH RePORTER |
| R01 DK107502 | NIDDK NIH HHS | United States | R01DK107502 | PubMed | NIH RePORTER |
| T32 GM063483 | NIGMS NIH HHS | United States | T32GM063483 | PubMed and NIH | NIH RePORTER |
| P30 AR070549 | NIAMS NIH HHS | United States | P30AR070549 | PubMed and NIH | NIH RePORTER |
| T32 AI118697 | NIAID NIH HHS | United States | T32AI118697 | PubMed and NIH | NIH RePORTER |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 33205070 | Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. | https://conductscience.org/library/papers/33205070 | PubMed |
| Comment in | 33205057 | CAR NK Cell Therapy for T Follicular Helper Cells. | https://conductscience.org/library/papers/33205057 | PubMed |
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22549246 | Follicular helper T cells in immunity and systemic autoimmunity. | Nat Rev Rheumatol | 2012 | https://conductscience.org/library/papers/22549246 | PubMed |
| 2 | 29192160 | A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice. | Sci Rep | 2017 | https://conductscience.org/library/papers/29192160 | PubMed |
| 3 | 27695002 | Suppression by TFR cells leads to durable and selective inhibition of B cell effector function. | Nat Immunol | 2016 | https://conductscience.org/library/papers/27695002 | PubMed |
| 4 | 27014270 | Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells. | Front Immunol | 2016 | https://conductscience.org/library/papers/27014270 | PubMed |
| 5 | 28150777 | Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. | Nature | 2017 | https://conductscience.org/library/papers/28150777 | PubMed |
| 6 | 32023374 | Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32023374 | PubMed |
| 7 | 25581113 | Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. | Arthritis Rheumatol | 2015 | https://conductscience.org/library/papers/25581113 | PubMed |
| 8 | 27501245 | Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. | Nature | 2016 | https://conductscience.org/library/papers/27501245 | PubMed |
| 9 | 24274181 | Chimeric antigen receptor therapy for cancer. | Annu Rev Med | 2014 | https://conductscience.org/library/papers/24274181 | PubMed |
| 10 | 30034945 | First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/30034945 | PubMed |
| 11 | 19221396 | Follicular helper T cells are required for systemic autoimmunity. | J Exp Med | 2009 | https://conductscience.org/library/papers/19221396 | PubMed |
| 12 | 24815671 | Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment. | Br J Haematol | 2014 | https://conductscience.org/library/papers/24815671 | PubMed |
| 13 | 27325434 | Follicular helper T cells mediate IgE antibody response to airborne allergens. | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/27325434 | PubMed |
| 14 | 30396745 | PD-1 immunobiology in systemic lupus erythematosus. | J Autoimmun | 2019 | https://conductscience.org/library/papers/30396745 | PubMed |
| 15 | 30666307 | Engineering and Design of Chimeric Antigen Receptors. | Mol Ther Methods Clin Dev | 2019 | https://conductscience.org/library/papers/30666307 | PubMed |
| 16 | 19935804 | Dysregulation of germinal centres in autoimmune disease. | Nat Rev Immunol | 2009 | https://conductscience.org/library/papers/19935804 | PubMed |
| 17 | 29605760 | Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering. | Curr Opin Immunol | 2018 | https://conductscience.org/library/papers/29605760 | PubMed |
| 18 | 15585893 | T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity. | J Immunol | 2004 | https://conductscience.org/library/papers/15585893 | PubMed |
| 19 | 20686503 | AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. | Leukemia | 2010 | https://conductscience.org/library/papers/20686503 | PubMed |
| 20 | 20033635 | Use of transfected Drosophila S2 cells to study NK cell activation. | Methods Mol Biol | 2010 | https://conductscience.org/library/papers/20033635 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42552386 | High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk. | Nat Genet | 2026 | https://conductscience.org/library/papers/42552386 | PubMed |
| 42498736 | Targeting T follicular helper cells for lifelong health. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/42498736 | PubMed |
| 42317359 | Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317359 | PubMed |
| 42030390 | Targeting PD-1+ T cells with chimeric antigen receptors to reduce the HIV reservoir. | Sci Adv | 2026 | https://conductscience.org/library/papers/42030390 | PubMed |
| 41573945 | High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk. | bioRxiv | 2026 | https://conductscience.org/library/papers/41573945 | PubMed |
| 41558532 | CAR-T cell therapy: A new dawn in the treatment of autoimmune disease. | Cell Transplant | 2026 | https://conductscience.org/library/papers/41558532 | PubMed |
| 41528734 | CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A. | Clin Exp Immunol | 2026 | https://conductscience.org/library/papers/41528734 | PubMed |
| 41329315 | A new era in CAR-NK cell therapy: from technological innovations to clinical applications. | World J Pediatr | 2026 | https://conductscience.org/library/papers/41329315 | PubMed |
| 41316450 | Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/41316450 | PubMed |
| 41145295 | [Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | https://conductscience.org/library/papers/41145295 | PubMed |
| 40747591 | Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40747591 | PubMed |
| 40524185 | Immune cell aberrations in Systemic Lupus Erythematosus: navigating the targeted therapies toward precision management. | Cell Mol Biol Lett | 2025 | https://conductscience.org/library/papers/40524185 | PubMed |
| 40481370 | From myth to bedside: a scoping review of the applications of the chimeric antigen receptor in rheumatology. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40481370 | PubMed |
| 40205818 | Diverse potential of chimeric antigen receptor-engineered cell therapy: Beyond cancer. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40205818 | PubMed |
| 39931050 | Cellular therapies in rheumatic and musculoskeletal diseases. | J Transl Autoimmun | 2025 | https://conductscience.org/library/papers/39931050 | PubMed |
| 39734406 | The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39734406 | PubMed |
| 39697333 | From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases. | Front Immunol | 2024 | https://conductscience.org/library/papers/39697333 | PubMed |
| 39511139 | Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39511139 | PubMed |
| 38920310 | Current cell therapies for systemic lupus erythematosus. | Stem Cells Transl Med | 2024 | https://conductscience.org/library/papers/38920310 | PubMed |
| 38656354 | A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases. | Med Oncol | 2024 | https://conductscience.org/library/papers/38656354 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32864635
GET https://conductscience.org/api/papers/v1/32864635/references?page=2